Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1976;53(4):435–443.

Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains*

A Ladefoged, K Bunch-Christensen, J Guld
PMCID: PMC2366516  PMID: 1086736

Abstract

In several previously reported studies a number of BCG strains, including those most widely used in vaccine production, were ranked according to their in vivo activity in various experimental models in rodents and to the local and allergic response that they provoked in children. In this report, 12 strains are ranked in terms of tuberculin conversion in guinea-pigs according to the minimum sensitizing dose. For 10 of these strains, this minimum dose is very low, ranging from 5 to 50 culturable particles. Thus the traditional practice of tuberculin-testing guinea-pigs that have been vaccinated with a full human dose of BCG (of the order of one million culturable particles) has such a low discriminating power that it is useless as a routine test for currently used vaccines. The ranking obtained in this model was largely but not completely in accordance with similar rankings in other models. The Tokyo strain and, to some extent, the London strain ranked comparatively lower than they do in children. The pronounced lack of virulence of the Prague strain was confirmed.

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjartveit K., Waaler H. Some evidence of the efficacy of mass BCG vaccination. Bull World Health Organ. 1965;33(3):289–319. [PMC free article] [PubMed] [Google Scholar]
  2. Bunch-Christensen K., Ladefoged A., Guld J. The virulence of some strains of BCG for golden hamsters. Bull World Health Organ. 1968;39(5):821–828. [PMC free article] [PubMed] [Google Scholar]
  3. DUBOS R. J., PIERCE C. H. Differential characteristics in vitro and in vivo of several substrains of BCG. IV. Immunizing effectiveness. Am Rev Tuberc. 1956 Nov;74(5):699–717. doi: 10.1164/artpd.1956.74.5.699. [DOI] [PubMed] [Google Scholar]
  4. JESPERSEN A. Antituberculous immunity induced in red mice (Clethrionomys G. glareolus Schreb.) by vaccination with living BCG. Acta Pathol Microbiol Scand. 1954;35(4):396–401. doi: 10.1111/j.1699-0463.1954.tb00884.x. [DOI] [PubMed] [Google Scholar]
  5. JESPERSEN A., BENTZON M. W. THE ACQUIRED RESISTANCE TO TUBERCULOSIS INDUCED BY BCG VACCINE ASSAYED BY A QUANTITATIVE METHOD ON RED MICE. CLETHRIONOMYS G. GLAREOLUS SCHREB. II. VACCINATION EFFECT OF BCG STRAINS STRONGLY OR MODERATELY VIRULENT FOR HAMSTERS. Acta Tuberc Pneumol Scand. 1964;44:276–289. [PubMed] [Google Scholar]
  6. JESPERSEN A. Studies on tuberculin sensitivity and immunity in guinea-pigs induced by vaccination with varying doses of BCG vaccine. Acta Pathol Microbiol Scand. 1956;38(3):203–210. doi: 10.1111/j.1699-0463.1956.tb03168.x. [DOI] [PubMed] [Google Scholar]
  7. Vallishayee R. S., Shashidhara A. N., Bunch-Christensen K., Guld J. Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains. Bull World Health Organ. 1974;51(5):489–494. [PMC free article] [PubMed] [Google Scholar]
  8. WILLIS S., VANDIVIERE M. The heterogeneity of BCG. Am Rev Respir Dis. 1961 Aug;84:288–290. doi: 10.1164/arrd.1961.84.2.288. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES